Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 171.09
-2.13 (-1.23%)
At close: Sep 11, 2026
NSE:GKSL Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 154.97 | 94.13 | 17.14 | -0.06 | 0.98 |
Depreciation & Amortization | 47 | 32.9 | 3.19 | - | 5.74 |
Loss (Gain) From Sale of Assets | 0.1 | - | -7.02 | - | - |
Other Operating Activities | -22.72 | 12.58 | 5.29 | - | - |
Change in Accounts Receivable | -234.74 | -109.54 | 1.87 | 0.61 | -6.74 |
Change in Inventory | -13.8 | -4.05 | -2.7 | - | - |
Change in Accounts Payable | 52.09 | 10.53 | -36.8 | -0.54 | 0.03 |
Change in Other Net Operating Assets | -21.53 | 99.53 | 31.16 | - | - |
Operating Cash Flow | -38.62 | 136.08 | 12.13 | 0 | 0.02 |
Operating Cash Flow Growth | - | 1022.03% | 700940.46% | -92.56% | -99.94% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -698.14 | -111.16 | - | - | - |
Sale of Property, Plant & Equipment | - | - | 4.26 | - | - |
Cash Acquisitions | -836.01 | -71.31 | - | - | - |
Sale (Purchase) of Real Estate | -120 | - | - | - | - |
Investment in Securities | -492.5 | -0.06 | -2.05 | - | - |
Other Investing Activities | 8.13 | 1.08 | 0.02 | - | - |
Investing Cash Flow | -2,139 | -181.45 | 2.23 | - | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 121.94 | 13.22 | - | - | - |
Long-Term Debt Issued | 11.72 | 6.14 | - | - | - |
Total Debt Issued | 133.66 | 19.36 | - | - | - |
Long-Term Debt Repaid | -3.58 | -1.96 | -0.58 | - | - |
Lease Payments | - | -1.96 | -0.18 | - | - |
Net Debt Issued (Repaid) | 130.08 | 17.4 | -0.58 | - | - |
Issuance of Common Stock | 2,508 | 54 | - | - | - |
Other Financing Activities | -354.03 | -9.78 | -4.11 | - | - |
Financing Cash Flow | 2,284 | 61.62 | -4.69 | - | - |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 106.86 | 16.26 | 9.67 | 0 | 0.02 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -736.76 | 24.92 | 12.13 | 0 | 0.02 |
Free Cash Flow Growth | - | 105.47% | 700940.46% | -92.56% | - |
Free Cash Flow Margin | -89.83% | 6.19% | 25.40% | - | 0.30% |
Free Cash Flow Per Share | -11.82 | 0.49 | 0.35 | - | 0.00 |
Levered Free Cash Flow | -882.61 | 25.98 | -32.05 | 0.02 | 0.05 |
Unlevered Free Cash Flow | -871.2 | 29.96 | -31.65 | 0.04 | 0.11 |
Free Cash Flow After Leases | -736.76 | 22.96 | 11.95 | 0 | 0.02 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 18.26 | 6.37 | 0.64 | - | - |
Cash Income Tax Paid | 94.72 | 27.64 | 1.74 | - | 0.36 |
Change in Working Capital | -217.97 | -3.53 | -6.48 | 0.06 | -6.7 |